Close

P-1A

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Upon infection, CD4 T cells scan antigen-presenting cells (APCs) for pathogen-derived peptides displayed on host MHC class II proteins (pMHCII). If a T-cell–APC encounter results in intracellular signals that exceed a threshold, naïve CD4 T cells are triggered to undergo clonal expansion and acquire effector cell functions that help eliminate pathogens.
  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-YC0807 Mouse anti-P-1A T cell receptor (506beta), pCDTCR1 Aequorea victoria 506beta Mouse FAAQKAKANKAVD H2-IAb Lentiviral vector   Add to Cart   Datasheet
TCR-YC0808 Mouse anti-P-1A T cell receptor (B3K506), pCDTCR1 B3K506 Mouse FAAQKAKANKAVD H2-IAb Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.